First Time Loading...

IVF Hartmann Holding AG
SIX:VBSN

Watchlist Manager
IVF Hartmann Holding AG Logo
IVF Hartmann Holding AG
SIX:VBSN
Watchlist
Price: 143 CHF 2.14% Market Closed
Updated: Apr 28, 2024

Intrinsic Value

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. [ Read More ]

The intrinsic value of one VBSN stock under the Base Case scenario is 121.26 CHF. Compared to the current market price of 143 CHF, IVF Hartmann Holding AG is Overvalued by 15%.

Key Points:
VBSN Intrinsic Value
Base Case
121.26 CHF
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IVF Hartmann Holding AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling VBSN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
IVF Hartmann Holding AG

Provide an overview of the primary business activities
of IVF Hartmann Holding AG.

What unique competitive advantages
does IVF Hartmann Holding AG hold over its rivals?

What risks and challenges
does IVF Hartmann Holding AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IVF Hartmann Holding AG.

Provide P/S
for IVF Hartmann Holding AG.

Provide P/E
for IVF Hartmann Holding AG.

Provide P/OCF
for IVF Hartmann Holding AG.

Provide P/FCFE
for IVF Hartmann Holding AG.

Provide P/B
for IVF Hartmann Holding AG.

Provide EV/S
for IVF Hartmann Holding AG.

Provide EV/GP
for IVF Hartmann Holding AG.

Provide EV/EBITDA
for IVF Hartmann Holding AG.

Provide EV/EBIT
for IVF Hartmann Holding AG.

Provide EV/OCF
for IVF Hartmann Holding AG.

Provide EV/FCFF
for IVF Hartmann Holding AG.

Provide EV/IC
for IVF Hartmann Holding AG.

Compare the intrinsic valuations
of IVF Hartmann Holding AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IVF Hartmann Holding AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of IVF Hartmann Holding AG compared to its peers.

Compare the P/E ratios
of IVF Hartmann Holding AG against its peers.

Discuss the investment returns and shareholder value creation
comparing IVF Hartmann Holding AG with its peers.

Analyze the financial leverage
of IVF Hartmann Holding AG compared to its main competitors.

Show all profitability ratios
for IVF Hartmann Holding AG.

Provide ROE
for IVF Hartmann Holding AG.

Provide ROA
for IVF Hartmann Holding AG.

Provide ROIC
for IVF Hartmann Holding AG.

Provide ROCE
for IVF Hartmann Holding AG.

Provide Gross Margin
for IVF Hartmann Holding AG.

Provide Operating Margin
for IVF Hartmann Holding AG.

Provide Net Margin
for IVF Hartmann Holding AG.

Provide FCF Margin
for IVF Hartmann Holding AG.

Show all solvency ratios
for IVF Hartmann Holding AG.

Provide D/E Ratio
for IVF Hartmann Holding AG.

Provide D/A Ratio
for IVF Hartmann Holding AG.

Provide Interest Coverage Ratio
for IVF Hartmann Holding AG.

Provide Altman Z-Score Ratio
for IVF Hartmann Holding AG.

Provide Quick Ratio
for IVF Hartmann Holding AG.

Provide Current Ratio
for IVF Hartmann Holding AG.

Provide Cash Ratio
for IVF Hartmann Holding AG.

What is the historical Revenue growth
over the last 5 years for IVF Hartmann Holding AG?

What is the historical Net Income growth
over the last 5 years for IVF Hartmann Holding AG?

What is the current Free Cash Flow
of IVF Hartmann Holding AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for IVF Hartmann Holding AG.

Financials

Balance Sheet Decomposition
IVF Hartmann Holding AG

Current Assets 131.5m
Cash & Short-Term Investments 39.8m
Receivables 65m
Other Current Assets 26.8m
Non-Current Assets 48.8m
PP&E 45.1m
Intangibles 3.7m
Current Liabilities 32.4m
Accounts Payable 4.3m
Accrued Liabilities 12.5m
Other Current Liabilities 15.6m
Non-Current Liabilities 4.2m
Long-Term Debt 504k
Other Non-Current Liabilities 3.7m
Efficiency

Earnings Waterfall
IVF Hartmann Holding AG

Revenue
150.6m CHF
Cost of Revenue
-70m CHF
Gross Profit
80.6m CHF
Operating Expenses
-67.3m CHF
Operating Income
13.3m CHF
Other Expenses
-2.1m CHF
Net Income
11.2m CHF

Free Cash Flow Analysis
IVF Hartmann Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

VBSN Profitability Score
Profitability Due Diligence

IVF Hartmann Holding AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 1-Year Revenue Growth
Positive 3-Year Average ROIC
52/100
Profitability
Score

IVF Hartmann Holding AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

VBSN Solvency Score
Solvency Due Diligence

IVF Hartmann Holding AG's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

IVF Hartmann Holding AG's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VBSN Price Targets Summary
IVF Hartmann Holding AG

There are no price targets for VBSN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

VBSN Price
IVF Hartmann Holding AG

1M 1M
+1%
6M 6M
+38%
1Y 1Y
+24%
3Y 3Y
-15%
5Y 5Y
+2%
10Y 10Y
+47%
Annual Price Range
143
52w Low
103
52w High
144
Price Metrics
Average Annual Return -1.65%
Standard Deviation of Annual Returns 23.53%
Max Drawdown -45%
Shares Statistics
Market Capitalization 343.2m CHF
Shares Outstanding 2 388 245
Percentage of Shares Shorted
N/A

VBSN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

IVF Hartmann Holding AG Logo
IVF Hartmann Holding AG

Country

Switzerland

Industry

Health Care

Market Cap

343.2m CHF

Dividend Yield

2.24%

Description

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. The company is headquartered in Neuhausen Am Rheinfall, Schaffhausen and currently employs 340 full-time employees. The company went IPO on 2012-07-16. The firm's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The firm also offers consulting services, on-site or in classrooms, related to the usage of its products. The firm's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. The company also operates subsidiaries located in Switzerland.

Contact

SCHAFFHAUSEN
NEUHAUSEN AM RHEINFALL
Victor-von-Bruns-Strasse 28

IPO

2012-07-16

Employees

340

Officers

Chief Executive Officer
Dr. Claus Martini
Chief Financial Officer
Dr. Hannes Leu
Chief Operations Officer
Mr. Bernd Deny

See Also

Discover More
What is the Intrinsic Value of one VBSN stock?

The intrinsic value of one VBSN stock under the Base Case scenario is 121.26 CHF.

Is VBSN stock undervalued or overvalued?

Compared to the current market price of 143 CHF, IVF Hartmann Holding AG is Overvalued by 15%.